Express News | Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger

BreakingsOct 15 20:00

Press Release: Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger

Dow JonesOct 15 20:00

Peak Bio Incentivizes Leadership With Stock Options for Growth

TipRanksOct 1 05:48

Akari Therapeutics Merges With Peak Bio to Advance Autoimmune Treatments

TipRanksSep 19 04:58

Express News | Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics

BreakingsSep 17 20:00

Peak Bio Announces CEO Transition and New Leadership

TipRanksSep 4 04:28